Life sciences firm HealthTell has raised $4m from private backers to bring to market a test kit for lung, breast, prostate, and colorectal cancer. The US-based firm, founded in 2010, is commercialising diagnostics technology originally developed at Arizona State University’s (ASU) Biodesign Institute. It is currently housed at the Innovations Incubator at Chandler, Arizona, where…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
